Every material Form 8-K Soren Acquisition Corp. has filed with the SEC since January 16, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
On October 20, 2026, Soren Acquisition Corp. replaced its chief financial officer and changed three of its board seats, with Joseph Tonnos becoming CFO in place of Jamie Weber, who also resigned as a director. Arghavan Di Rezze remains chief executive officer. The filing reports no financial results, and the compensation for the new directors and CFO has not been determined.
Joseph Tonnos was appointed CFO effective October 20, 2026, succeeding Jamie Weber, who resigned as CFO and director.
Spencer Gerrol and Charles N. Kahn III resigned as directors effective October 20, 2026; Roger Cloutier Jr., Austin Criden and Joseph Tonnos filled the three vacancies.
Compensation for the new directors and CFO has not been determined; each is expected to receive an indirect economic interest in founder shares held by sponsor Soren Holdings LLC.
The company furnished an October 26, 2026 press release announcing the appointments as Exhibit 99.1.
Soren Acquisition Corp., a blank check company focused on healthcare, said holders of its units may separately trade Class A ordinary shares and warrants starting February 27, 2026. Units not separated will continue to trade under the symbol SORNU, so the change affects how existing units can be held rather than the company's financial position.
Separate trading of Class A ordinary shares (SORN) and warrants (SORNW) begins February 27, 2026 on the Nasdaq Global Market.
Each unit holds one Class A ordinary share and one-third of one redeemable warrant, exercisable at $11.50 per share.
No fractional warrants will be issued; only whole warrants will trade.
Holders must have their brokers contact Continental Stock Transfer & Trust Company to separate units.
Soren Acquisition Corp., a blank check company with no selected acquisition target, closed its initial public offering on January 8, 2026, selling 25.3 million units at $10.00 each for $253 million in gross proceeds. The full $253 million was placed in a U.S. trust account, which shareholders can access only through a business combination, a shareholder-approved amendment, or redemption if no deal closes within 24 months.
IPO of 25,300,000 units at $10.00 per unit closed January 8, 2026, including 3,300,000 units from the underwriters' over-allotment option
Gross proceeds of $253,000,000 placed in a trust account maintained by Continental Stock Transfer & Trust Company
Sponsor Soren Holdings LLC bought 5,000,000 private placement warrants at $1.00 each, for $5,000,000 in gross proceeds
Company has 24 months from the IPO closing to complete an initial business combination
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Soren Acquisition Corp. filing is on SEC EDGAR ↗. 8-K briefs of other companies →